title: Electrophysiologic effects of intravenous xamoterol in patients with sinus node dysfunction.
abstract: The electrophysiologic effects of xamoterol were studied in ten patients with electrophysiologic evidence of sinus node dysfunction. A significant shortening of mean sinus cycle length, maximal corrected sinus-node recovery time, and the mean of the three longest corrected sinus-node recovery times was observed after intravenous administration of 0.1 mg/kg of xamoterol. The atrioventricular (AV) conduction time and the effective and functional refractory periods of the AV node were shortened as the effective refractory period of the atrium. These effects suggest that xamoterol could be tried safely for the treatment of patients with moderate symptoms due to sinus-node disease.
authors.affiliation: Cardiology Department, Saint-Pierre University Hospital, Brussels, Belgium.
authors.forename: M
authors.initials: M
authors.lastname: de Marneffe
authors.forename: P
authors.initials: P
authors.lastname: Waterschoot
authors.forename: A
authors.initials: A
authors.lastname: Bernard
authors.forename: P
authors.initials: P
authors.lastname: Dubois
authors.forename: F
authors.initials: F
authors.lastname: Boujelben
authors.forename: I
authors.initials: I
authors.lastname: Liebens
authors.forename: M
authors.initials: M
authors.lastname: Englert
mesh_terms: D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004562:Electrocardiography / Q000187:drug effects*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000627:therapeutic use*; D012849:Sinoatrial Node / Q000187:drug effects*; D017307:Xamoterol
chemical_list: D000318:Adrenergic beta-Agonists; D011412:Propanolamines; D017307:Xamoterol